GSNOR overexpression enhances CAR-T cell stemness and anti-tumor function by enforcing mitochondrial fitness
Molecular Therapy · 2024-06 · 32 (6) · 1875-1894
DOI: 10.1016/j.ymthe.2024.03.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2024-06. Verfasst von Qing Niu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Mitochondria, Receptors, Chimeric Antigen, Immunotherapy, Adoptive. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Municipal Natural Science Foundation, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Chimeric antigen receptor-T (CAR-T) cell has been developed as a promising agent for patients with refractory or relapsed lymphoma and leukemia, but not all the recipients could achieve a long-lasting remission. The limited capacity of in vivo expansion and memory differentiation post activation is one of the major reasons for suboptimal CAR-T therapeutic efficiency. Nitric oxide (NO) plays multifaceted roles in mitochondrial dynamics and T cell activation, but its function on CAR-T cell persistence and anti-tumor efficacy remains unknown. Herein, we found the continuous signaling from CAR not only promotes excessive NO production, but also suppressed S-nitrosoglutathione reductase (GSNOR) expression in T cells, which collectively led to increased protein S-nitrosylation, resulting in impaired mitochondrial fitness and deficiency of T cell stemness. Intriguingly, enforced expression of GSNOR promoted memory differentiation of CAR-T cell after immune activation, rendered CAR-T better resistance to mitochondrial dysfunction, further enhanced CAR-T cell expansion and anti-tumor capacity in vitro and in a mouse tumor model. Thus, we revealed a critical role of NO in restricting CAR-T cell persistence and functionality, and defined that GSNOR overexpression may provide a solution to combat NO stress and render patients with more durable protection from CAR-T therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
- Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
- Department of Hematology, Hematology Research Center of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
Förderung
- National Natural Science Foundation of China
- Tianjin Municipal Natural Science Foundation
- CAMS Innovation Fund for Medical Sciences
- Tianjin Municipal Education Commission
- National Key Research and Development Program of China Stem Cell and Translational Research
- Chinese Academy of Meteorological Sciences
- National Key Research and Development Program of China
- Tianjin Municipal Science and Technology Committee
Zitieren
APA
Niu, Q., Zhang, H., Wang, F., Xu, X., Luo, Y., He, B., Shi, M., Jiang, E., & Feng, X. (2024). GSNOR overexpression enhances CAR-T cell stemness and anti-tumor function by enforcing mitochondrial fitness. Molecular Therapy, 32(6), 1875-1894. https://doi.org/10.1016/j.ymthe.2024.03.033
Vancouver
Niu Q, Zhang H, Wang F, Xu X, Luo Y, He B, et al. GSNOR overexpression enhances CAR-T cell stemness and anti-tumor function by enforcing mitochondrial fitness. Molecular Therapy. 2024;32(6):1875-1894. doi:10.1016/j.ymthe.2024.03.033
BibTeX
@article{Niu2024,
author = {Niu, Qing and Zhang, Haixiao and Wang, Fang and Xu, Xing and Luo, Yuechen and He, Baolin and Shi, Mingxia and Jiang, Erlie and Feng, Xiaoming},
title = {GSNOR overexpression enhances CAR-T cell stemness and anti-tumor function by enforcing mitochondrial fitness},
journal = {Molecular Therapy},
year = {2024},
volume = {32},
number = {6},
pages = {1875--1894},
doi = {10.1016/j.ymthe.2024.03.033}
}
EUVIMED